Business Context and Reporting Period
This Form 6-K filing by CollPlant Biotechnologies Ltd. is dated September 16, 2019. The report serves to notify shareholders of an upcoming Extraordinary General Meeting scheduled for October 27, 2019, in Tel-Aviv, Israel. The filing incorporates by reference into the company's Registration Statements on Form S-8 and Form F-3.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The primary event is the announcement of the shareholder meeting and the distribution of voting materials.
Guidance, Outlook, and Management Commentary
The filing provides no financial guidance, outlook, or management commentary regarding business strategy. It details the logistics of the Extraordinary General Meeting, including:
- Date and Time: October 27, 2019, at 10:00 a.m. Israel time.
- Location: Offices of Gross, Kleinhendler, Hodak, Halevy, Greenberg, Shenhav & Co., One Azrieli Center, Tel-Aviv.
- Attached Documents: Notice and Proxy Statement (Exhibit 99.1), Proxy Card for ordinary shares (Exhibit 99.2), and Voting Instruction Card for ADS holders (Exhibit 99.3).
Key Facts for Investor Verification
- Verify the specific proposals to be voted upon in the attached Notice and Proxy Statement (Exhibit 99.1), as the summary text does not list them.
- Confirm the record date for shareholder eligibility, which is not explicitly stated in this cover letter.
- Check the company's Form 20-F for the most recent audited financial results, as this 6-K contains no financial data.
- Note that the filing was signed by Eran Rotem, Deputy CEO and Chief Financial Officer.